Incannex Healthcare (IXHL) Long-Term Deferred Tax (2020 - 2023)
Incannex Healthcare (IXHL) posted quarterly Long-Term Deferred Tax of $4.0 million for Q2 2023, up 18.82% year-on-year from $3.4 million in Q2 2022, and up 18.82% on a QoQ basis from $3.4 million in Q2 2022.
Incannex Healthcare (IXHL) Long-Term Deferred Tax (2020 - 2023) Analysis & Trends
Incannex Healthcare (IXHL) has reported Long-Term Deferred Tax for 4 consecutive years, with $4.0 million the latest figure, recorded in Q2 2023.
- Quarterly Long-Term Deferred Tax rose 18.82% year-over-year to $4.0 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $4.0 million (up 18.82% YoY) and the FY2023 annual result came in at $4.0 million, up 18.82% from the prior year.
- Long-Term Deferred Tax climbed to $4.0 million in Q2 2023 per IXHL's latest filing, from $3.4 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for IXHL reached as high as $4.0 million in Q2 2023 and fell as low as $1.1 million in Q2 2020.
- A 4-year average of $2.6 million and a median of $2.6 million in 2021 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2022 — Long-Term Deferred Tax jumped 90.2% — and 2023, when it climbed 18.82%.
- Year by year, Long-Term Deferred Tax stood at $1.1 million in 2020, then jumped by 55.31% to $1.8 million in 2021, then soared by 90.2% to $3.4 million in 2022, then gained by 18.82% to $4.0 million in 2023.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $4.0 million, $3.4 million, and $1.8 million for Q2 2023, Q2 2022, and Q2 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 3.99 Mn |
| Jun 30, 2022 | 3.36 Mn |
| Jun 30, 2021 | 1.76 Mn |
| Jun 30, 2020 | 1.14 Mn |